Accelerating Time to Diagnosis for Ultra-Rare Diseases with Veeva Compass

Orchard Therapeutics, a London-based biotech, needed to efficiently identify healthcare professionals treating ultra-rare-disease patients. It implemented Veeva Compass, which provides daily data for building algorithms to locate patients and their treating physicians. Brian Campbell, VP and General Manager at Orchard, is quoted: 'Veeva Compass and the data model...allows us to quickly, with quality data, put algorithms together to effectively identify where appropriate patients are potentially being treated.' The page is primarily a video-led testimonial and does not provide specific quantitative outcomes.

Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.